The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial
BMC Endocrine Disorders · 2024
DOI: 10.1186/s12902-024-01738-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Alireza Ostadrahimi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Endocannabinoids, Oleic Acids, Obesity, Feeding Behavior. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Abnormalities in biochemical parameters and changes in eating habits are considered complications of obesity. Oleoylethanolamide (OEA), an endocannabinoid-like compound, has been shown to have protective effects on many metabolic disorders. Given this evidence, the present study aimed to assess the effects of OEA on lipid profile parameters, fasting blood sugar (FBS), and dietary habits in healthy obese people.
Methods
In this randomized, double-blind, placebo-controlled clinical trial, which was carried out in 2016 in Tabriz, Iran, 60 obese people were enrolled in the study based on inclusion criteria. The intervention group consumed 125 mg of OEA capsules, and the placebo group received the same amount of starch twice for 8 weeks. Blood samples (5 mL) were taken at baseline and the end of the study in a fasting state. Serum concentrations of FBS, triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), and total cholesterol (TC) were measured by enzymatic methods using commercial kits. The low-density lipoprotein cholesterol (LDL-C) concentration was obtained using the Friede-Wald formula. To assess dietary habits, a food frequency questionnaire (147 items) was used at baseline and the end of the study. A value less than < 0.05 was considered to indicate statistical significance.
Results
The TG concentration decreased significantly in the intervention group (mean (SD): 166.29 (70.01) mg/dL to 142.22 (48.05) mg/dL, p = 0.047). Changes in the placebo group were not significant ( p > 0.05). After adjusting for baseline values and demographic characteristics, the difference in TG between groups remained significant ( p = 0.044). Changes in other biochemical parameters were not significant. There was no significant difference between or within groups in terms of food groups.
Conclusion
OEA, as a complementary agent, plays a protective role in TG regulation. However, future studies with longer durations are needed to explore the impact of OEA on regulating dietary habits and to identify the mechanisms related to metabolic abnormalities in obese people. Trial Registration The study was registered in the Iranian Registry of Clinical Trials (IRCT) center as IRCT201607132017N30 with URL. www.IRCT.IR in date 03/10/2016.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Nutrition Sciences, Department of Nutrition, Maragheh University of Medical Sciences, Maragheh, Iran.
- Student Research Committee, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. llllpayahoo44@gmail.com.
- Nutrition Sciences, Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran. llllpayahoo44@gmail.com.
Zitieren
APA
Ostadrahimi, A., Khajebishak, Y., Moradi, F., & Payahoo, L. (2024). The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01738-7
Vancouver
Ostadrahimi A, Khajebishak Y, Moradi F, Payahoo L. The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01738-7
BibTeX
@article{Ostadrahimi2024,
author = {Ostadrahimi, Alireza and Khajebishak, Yaser and Moradi, Fardin and Payahoo, Laleh},
title = {The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial},
journal = {BMC Endocrine Disorders},
year = {2024},
doi = {10.1186/s12902-024-01738-7}
}
EUVIMED